Le Lézard
Classified in: Health
Subject: SVY

Global $7.65 Billion Specialty Medical Chairs Market 2014-2017 & 2025 - Examination Chairs, Treatment Chairs, Rehabilitation Chairs


DUBLIN, November 24, 2017 /PRNewswire/ --

The "Specialty Medical Chairs Market Analysis By Product (Examination Chairs, Treatment Chairs, Rehabilitation Chairs), By Region, And Segment Forecasts, 2014 - 2025" report has been added to Research and Markets' offering.

Research and Markets Logo

The global specialty medical chairs market is expected to reach USD 7.65 billion by 2025

Increasing geriatric population is expected to boost the adoption of specialty medical chairs. As per WHO, it is estimated that from 2025 to 2050, the older population is expected to almost double to 1.6 billion globally. According to The World Bank, population in Asia Pacific region is aging rapidly. More than 211 million people aged 65 years and above were living in East Asia and Pacific in 2010. The older population is expected to grow by 22% every five years in East Asia. This shows the potential demand for these equipment in the coming years.

As per the European Health Interview Survey (EHIS), 51.6 % of the European populace (18 years and above) was overweight in 2014. Rising prevalence of lifestyle-associated diseases, such as diabetes, obesity, chronic kidney disease, and cardiovascular disease, is increasing patient base for the adoption of these products. Furthermore, growing disabled population as a result of a rise in incidence of paralysis and spinal injuries is anticipated to drive the market to some extent. According to CDC, 53 million people in the U.S. are living with a disability.

Increasing reimbursement policies and supportive regulatory framework in developed nations are pushing the market growth. For instance, Medicare policies in the U.S. offer reimbursement for equipment such as wheel chairs, recliners, and other specialty medical chairs. In addition, key market players are offering customized products to meet the various needs of doctors and patients. Rising demand for new products, changing lifestyle, ease of use, and better facilities are factors expected to provide lucrative opportunities.

Key Topics Covered:

Chapter 1 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Specialty Medical Chairs Market Variables, Trends & Scope

Chapter 4 Specialty Medical Chairs Market: Product Estimates & Trend Analysis

Chapter 5 Specialty Medical Chairs Market: Regional Estimates & Trend Analysis, by Product

Chapter 6 Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/bbvxnk/specialty_medical

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: